FBInvestor
Stocks / Silo Pharma Inc
Institutional Ownership

Silo Pharma Inc

CUSIP 82711P201COM NEWSILOQ1 2026

13D / 13G Filings
15
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
11.0%
Max % of class reported
Institutional Holders
13
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

15 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Anson Funds Management LP13G/A4.9%699.5KSEC
2Feb 13, 2026Mitchell P. Kopin13G/A10.0%1.48MSEC
3Feb 13, 2026Seg Opportunity Fund, LLC13G/A11.0%9SEC
4Nov 14, 2025Anson Funds Management LP13G7.2%952.4KSEC
5Nov 7, 2025Mitchell P. Kopin13G/A10.0%1.38MSEC
6Oct 3, 2025Seg Opportunity Fund, LLC13G11.0%952.4KSEC
7Aug 12, 2025Mitchell P. Kopin13G/A10.0%838.1KSEC
8May 21, 2025Mitchell P. Kopin13G10.0%784.6KSEC
9Feb 13, 2025Renaissance Technologies LLC13G/A0.8%37.5KSEC
10Nov 13, 2024Renaissance Technologies LLC13G5.1%227.0KSEC

5 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Silo Pharma Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →